Biotech Analysts, along with Dr. Baldwin, CEO of Opthea, Dr. Pieramici of California Retina Consultants and Dr. Wykoff of Retina Consultants of Texas, in conjunction with the American Society of Retina Specialists (ASRS) 41st Annual Meeting, discuss market trends and new treatments in wet age-related macular degeneration (wAMD) on an Analyst/Industry conference call to be held on August 1 at 11 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on OPT:
- Opthea to Present at the 2023 Ophthalmology Innovation Summit
- Opthea to Feature at the American Society of Retina Specialists 2023 Annual Meeting
- Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical Advisor
- Opthea announces resignation of Chief Medical Officer Dr. Joel Naor
- Opthea Appoints Anshul Thakral as Non-Executive Director of the Board
